Idexx Laboratories (IDXX) Income from Continuing Operations (2009 - 2026)

Idexx Laboratories' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 278446000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 14.74% year-over-year to 278446000.0; the TTM figure through Mar 2026 stood at 1095233000.0 (up 22.38% YoY), while the FY2025 annual figure was 1059464000.0, up 19.33% from the prior year.
• Income from Continuing Operations was 278446000.0 for Q1 2026 at Idexx Laboratories, up from 248188000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 293989000.0 in Q2 2025 to a low of 131979000.0 in Q2 2022.
• Historically, Income from Continuing Operations has averaged 220582823.53 across 5 years, with a median of 216149000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations plunged 34.86% in 2022, then soared 69.9% in 2023.
• A 5-year view of Income from Continuing Operations shows it stood at 172207000.0 in 2022, then climbed by 12.96% to 194521000.0 in 2023, then increased by 11.12% to 216149000.0 in 2024, then climbed by 14.82% to 248188000.0 in 2025, then gained by 12.19% to 278446000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 278446000.0 (Q1 2026), 248188000.0 (Q4 2025), and 274610000.0 (Q3 2025), per Business Quant data.